Editorial: Myelin-Mediated Inhibition of Axonal Regeneration: Past, Present, and Future

Hannila, Sari S.; Mellado, Wilfredo

doi:10.3389/fnmol.2017.00113

Cited by 1 publication

(1 citation statement)

References 23 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As myelin forms part of a matured and intact neuron when damaged, it acts as a hindrance to the regeneration process by accumulating debris and expressing certain growth inhibitory factors within myelin. Inhibitors like Nogo, MAG, oligodendrocyte myelin glycoprotein (Omgp) break down the newly formed growth cone terminating axonal growth (Filbin 2003;Hannila and Mellado 2017;Maugeri et al 2020).…”

Section: Myelin: From Conduction To Growth Inhibitionmentioning

confidence: 99%

A Review on the Role of Endogenous Neurotrophins and Schwann Cells in Axonal Regeneration

Pandey

Mudgal

2021

J Neuroimmune Pharmacol

View full text Add to dashboard Cite

Injury to the peripheral nerve is traditionally referred to acquired nerve injury as they are the result of physical trauma due to laceration, stretch, crush and compression of nerves. However, peripheral nerve injury may not be completely limited to acquired physical trauma. Peripheral nerve injury equally implies clinical conditions like Guillain-Barré syndrome (GBS), Carpal tunnel syndrome, rheumatoid arthritis and diabetes. Physical trauma is commonly mono-neuropathic as it engages a single nerve and produces focal damage, while in the context of pathological conditions the damage is divergent involving a group of the nerve causing polyneuropathy. Damage to the peripheral nerve can cause a diverse range of manifestations from sensory impairment to loss of function with unpredictable recovery patterns. Presently no treatment option provides complete or functional recovery in nerve injury, as nerve cells are highly differentiated and inert to regeneration. However, the regenerative phenotypes in Schwann cells get expressed when a signalling cascade is triggered by neurotrophins. Neurotrophins are one of the promising biomolecules that are released naturally post-injury with the potential to exhibit better functional recovery. Pharmacological intervention modulating the expression of these neurotrophins such as brain-derived neurotrophic factor (BDNF) and pituitary adenylyl cyclase-activating peptide (PACAP) can prove to be a significant treatment option as endogenous compounds which may have remarkable innate advantage showing maximum ‘biological relevance’. Graphical abstract

show abstract

Section: Myelin: From Conduction To Growth Inhibitionmentioning

confidence: 99%